comparemela.com

Latest Breaking News On - Urologic oncology annual meeting - Page 2 : comparemela.com

TULSA Provides Durable Disease Control for Patients With Prostate Cancer

MRI-guided TULSA can provide long-term disease control in patients with localized prostate cancer, according to researchers. MRI-guided TULSA can provide long-term disease control in patients with localized prostate cancer, according to researchers.

High MAP Scores Linked to Inferior OS in RCC Patients Undergoing Nephrectomy

Mayo Adhesive Probability scores can predict overall survival in patients undergoing surgery for T1 renal cell carcinoma, according to researchers. MAP scores can predict overall survival in patients undergoing surgery for T1 RCC, according to researchers.

Integrating Genomic and Clinicopathologic Risk Groups May Improve Prognostication in Prostate Cancer

Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.

Why Patients With Bladder Cancer Aren t Receiving Recommended Immunotherapy

Age, sex, insurance status, and other factors were associated with receipt of immunotherapy in a study of patients with metastatic bladder cancer. Age, sex, insurance status, and other factors were associated with receipt of immunotherapy in patients with metastatic bladder cancer.

ChatGPT Exhibits Poor Performance When Classifying Patients With Prostate Cancer

ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests. ChatGPT produces mixed results when evaluating patients with prostate cancer, new research suggests.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.